A Phase II Trial of Induction Systemic Mfolfirinox Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone Given Concurrently with Systemic Mfolfiri As a First-Line Therapy in Patients with Unresectable Liver-Dominant Intrahepatic Cholangiocarcinoma (HELIX-1).
Journal of Clinical Oncology（2024）
Key words
11890-11879-11918-11863,261-566-11347,261-492-3532-2370-5109,261-492-199,130-540-543-4790,281-9641-9439,281-318-430,127,53,127
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined